← All stocks

LIFECORE BIOMEDICAL, INC. DE

LFCR No buying or selling
CIK 0001005286 #4027 in the set updated 21 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

13 insiders · 0 transactions
7.6×

Paul Josephs holds 7.6 times base salary in stock. $4.22M of shares against $550.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Paul Josephs last reported holding, valued at $7.12, the price Common Stock was last bought or sold at on the open market here, on 28 May 2025.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I entity
10% owner
4,703,216
$33.50M
+6.6%
Josephs Paul
Chief Executive Officer
592,915
$4.22M
+14.9%
Kiper Christopher S
Director
422,768
$3.01M
Lake Ryan David
Chief Financial Officer
336,691
$2.40M
+28.3%
English Aron R.
10% owner
264,180
$1.88M
−84.9%
Salus Thomas D.
Chief Legal & Administration
246,333
$1.75M
OBUS NELSON
Director
164,100
$1.17M
+38.3%
HOUDE LOVAS KATRINA
Director
135,319
$963.99K
+50.5%
Schechter Joshua
Director
133,080
$948.04K
+51.8%
Antunes Humberto Calheiros
Director
72,967
$519.80K
+164.8%
Aryeh Jason
Director
69,967
$498.43K
+185.0%
Korenberg Matthew E
Director
69,967
$498.43K
+185.0%
Johnson Paul Harold
Director
69,967
$498.43K
+185.0%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 24 Oct 2016